Kinaxis (TSE:KXS – Get Free Report) has been given a C$210.00 price objective by analysts at RBC Dominion Securities in a research note issued on Friday, BayStreet reports. The brokerage currently has an “outperform” rating on the stock. RBC Dominion Securities‘s price target indicates a potential upside of 5.69% from the stock’s previous close.
A number of other brokerages have also recently weighed in on KXS. BMO Capital Markets upped their price target on shares of Kinaxis from C$195.00 to C$200.00 and gave the stock an “outperform” rating in a research report on Friday, August 7th. National Bank Financial increased their price target on Kinaxis from C$200.00 to C$210.00 and gave the company an “outperform” rating in a report on Friday, August 7th. Finally, Royal Bank Of Canada set a C$210.00 price objective on Kinaxis and gave the company an “outperform” rating in a research report on Wednesday, August 26th. Eight equities research analysts have rated the stock with a Buy rating. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of C$203.89.
Kinaxis Trading Up 0.1%
TSE KXS traded up C$0.29 during mid-day trading on Friday, hitting C$198.69. The company’s stock had a trading volume of 45,197 shares, compared to its average volume of 123,248. The firm has a market capitalization of C$5.40 billion, a P/E ratio of 64.93, a price-to-earnings-growth ratio of 3.60 and a beta of 0.58. The company has a debt-to-equity ratio of 11.14, a current ratio of 1.88 and a quick ratio of 2.29. Kinaxis has a 52-week low of C$117.22 and a 52-week high of C$201.57. The stock’s fifty day simple moving average is C$178.07 and its two-hundred day simple moving average is C$161.60.
Kinaxis (TSE:KXS – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported C$1.71 earnings per share (EPS) for the quarter. Kinaxis had a net margin of 14.40% and a return on equity of 20.88%. The company had revenue of C$225.60 million during the quarter. Research analysts expect that Kinaxis will post 4.25 EPS for the current year.
Insider Buying and Selling at Kinaxis
In related news, Director Robert G. Courteau sold 5,362 shares of Kinaxis stock in a transaction on Monday, August 24th. The shares were sold at an average price of C$178.39, for a total transaction of C$956,527.18. Following the sale, the director owned 37,898 shares of the company’s stock, valued at C$6,760,624.22. The trade was a 12.39% decrease in their position. Also, insider Andrew William Robert Bell sold 3,000 shares of Kinaxis stock in a transaction on Friday, August 21st. The stock was sold at an average price of C$179.48, for a total transaction of C$538,440.00. Following the sale, the insider directly owned 1,455 shares in the company, valued at C$261,143.40. This trade represents a 67.34% decrease in their position. In the last 90 days, insiders sold 33,730 shares of company stock worth $5,877,368. 1.20% of the stock is currently owned by insiders.
Kinaxis Company Profile
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.
Recommended Stories
- Five stocks we like better than Kinaxis
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
